Skip to content
    ENSG
    Earnings call· Mar 2026(Q1 FY26)

    ENSIGN GROUP Q1 FY26 earnings call ENSG

    May 1, 2026 Source

    Executive summary

    The Ensign Group, Inc. Q1 FY26 — Strong Occupancy and Raised Guidance

    The Ensign Group delivered a strong first quarter, driven by record occupancy and skilled mix growth, leading to an upward revision of its full-year earnings and revenue guidance. The company's diversified model and focus on high-acuity patient care continue to mitigate broader market concerns around managed care volumes and clinical reviews, reinforcing its position as a provider of choice. Strategic acquisitions and a robust leadership pipeline are expected to sustain healthy growth.

    Highlights

    5
    • Same-store and transitioning occupancy reached new record highs of 84.3% and 85.1%, respectively.

    • Annual 2026 earnings guidance increased to $7.48-$7.62 per diluted share, up from $7.41-$7.61.

    • Annual revenue guidance increased to $5.81 billion-$5.86 billion, up from $5.77 billion-$5.4 billion.

    • Adjusted diluted EPS increased by 21.7% to $1.85.

    • 85% of all operations achieved 4 or 5-star quality measures.

    Concerns

    3
    • Managed care volumes and increased clinical reviews

    • Seasonality in occupancy and skilled mix

    • State budget challenges impacting Medicaid rates

    Guidance & targets

    5
    CategoryTargetConfidence
    Annual 2026 Earnings per Diluted Share
    $7.48 to $7.62
    high materiality
    High
    Annual 2026 Revenue
    $5.81 billion to $5.86 billion
    high materiality
    High
    Diluted Weighted Average Common Shares Outstanding
    approximately $60 million
    low materiality
    High
    Tax Rate
    25%
    low materiality
    High
    CMS Proposed 2027 Skilled Nursing Facility Payment Rule Net Market Basket Increase
    2.4%
    medium materiality
    High

    Segment performance

    1
    SegmentRevenueYoYQoQMargin
    Standard Bearer Healthcare REIT
    Added 21 new assets during the quarter and since. Rental revenue includes $30.8 million derived from Ensign affiliated operations. Diversifying tenant base by adding relationships with unaffiliated operators.
    FFO: $21.6 millionEBITDAR to rent coverage ratio: 2.7xOwned properties: 173Leased to Ensign affiliated operators: 137Leased to third-party operators: 37
    $36.1 million

    Operational metrics

    40
    Same-store occupancy
    84.3record high
    Q1 FY26

    Reached a new record high during the quarter.

    Transitioning occupancy
    85.1record high
    Q1 FY26

    Reached a new record high during the quarter.

    Skilled revenue growth
    9.6YoY
    Q1 FY26

    Increase over the prior year quarter.

    Skilled days growth
    5.1YoY
    Q1 FY26

    Increase over the prior year quarter.

    Medicare revenue growth
    9.8YoY
    Q1 FY26

    Increase over the prior year quarter.

    Medicare days growth
    9.2YoY
    Q1 FY26

    Increase over the prior year quarter.

    Managed care census growth
    6.2sequential (Q4 to Q1)
    Q1 FY26

    Increased sequentially from Q4 to Q1.

    Medicare census growth
    8.3sequential (Q4 to Q1)
    Q1 FY26

    Increased sequentially from Q4 to Q1.

    Operations with 4 or 5-star quality measures
    85
    Q1 FY26

    Ended the quarter with 85% of all operations at 4 or 5-star quality measures.

    Directors of Nursing turnover decline
    32
    Past 2 years

    Turnover among Directors of Nursing has declined by 32% over the past 2 years.

    New operations acquired
    99
    Since 2024

    Successfully sourced, underwritten, closed, and transitioned.

    New operations acquired
    22
    During and since Q1 FY26

    Accelerated growth by adding 22 new operations, including 21 real estate assets.

    New skilled nursing beds added
    2662
    During and since Q1 FY26

    Added across 3 states through recent acquisitions.

    Senior living units added
    100
    During and since Q1 FY26

    Added across 3 states through recent acquisitions.

    Independent living units added
    55
    During and since Q1 FY26

    Added across 3 states through recent acquisitions.

    Recently acquired group of operations as % of portfolio
    17.4
    Q1 FY26

    The number of operations in the recently acquired group.

    Grossmont Post Acute beds added
    15
    Q1 FY26

    Added to the original license for a total of 105 beds in the new replacement facility.

    Grossmont Post Acute daily census increase
    from ~72 to 95
    Q1 FY26

    Increased daily census of skilled patients in just a few months of operation of the new facility.

    Cash and cash equivalents
    539.5
    As of March 31, 2026

    Key metric as of the end of the quarter.

    Strategic growth plan spend
    >60
    First 3 months of 2026

    Invested to execute on the strategic growth plan.

    Lease adjusted net debt-to-EBITDA ratio
    1.73
    Q1 FY26

    After taking investments into consideration, demonstrating commitment to disciplined growth.

    Available capacity under line of credit
    592
    Q1 FY26

    Combined with cash on balance sheet, provides over $1 billion for future investments.

    Owned assets
    179
    Q1 FY26

    155 of which are owned completely debt free, adding liquidity for future growth.

    Quarterly cash dividends per share
    0.065
    Q1 FY26

    Company paid quarterly cash dividends.

    Annual dividend increase streak
    23consecutive
    Q1 FY26

    Long history of paying dividends.

    Occupancy rate
    96up from 95% in Q1 FY25
    Q1 FY26

    Sun West consistently remains essentially full.

    Revenue growth
    10YoY
    Q1 FY26

    Driven by improved acuity-based reimbursement and higher skilled mix.

    Skilled mix days increase
    21
    Q1 FY26

    Fueled in large part by managed care growth.

    Managed care growth
    37
    Q1 FY26

    Contributed to skilled mix days increase.

    EBIT growth
    43YoY
    Q1 FY26

    Contributed by clinical strength and specialty units.

    CMS survey points score
    70better than the state average
    Q1 FY26

    Achieved a 5-star rating in CMS quality measures.

    Skilled mix days increase
    61YoY
    Q1 FY26

    Driving revenue growth and earnings increase.

    Revenue growth
    19
    Q1 FY26

    Driven by skilled mix days increase.

    Earnings increase
    163
    Q1 FY26

    Followed clinical gains and operational performance improvements.

    GAAP diluted EPS growth
    21.9YoY
    Q1 FY26

    GAAP diluted earnings per share was $1.67.

    Adjusted diluted EPS
    1.85up 21.7% YoY
    Q1 FY26

    Adjusted diluted earnings per share was $1.85, an increase of 21.7%.

    Consolidated GAAP and Adjusted Revenue growth
    18.4YoY
    Q1 FY26

    Consolidated GAAP revenue and adjusted revenues were both $1.4 billion, an increase of 18.4%.

    GAAP net income growth
    24.2YoY
    Q1 FY26

    GAAP net income was $99.7 million, an increase of 24.2%.

    Adjusted net income
    110.2up 23.9% YoY
    Q1 FY26

    Adjusted net income was $110.2 million, an increase of 23.9%.

    Occupancy rate for mature operations
    mid-90% range
    Ongoing

    Many of our most mature operations consistently achieve this range, representing embedded organic growth opportunity.

    Industry KPIs

    5
    MetricValueDetails
    Utilization trends5.1%
    Same facility volumesfrom ~72 to 95patients
    Stars rate environment85%
    Payer mix supplemental payments
    Adjusted EPS EBITDA leverage guidance$1.85$

    Product announcements

    1
    ProductTypeDetails
    Grossmont Post Acute replacement facilitylaunch

    Deals & partnerships

    1
    Various sellersAcquisition of 22 new operations, including 21 real estate assets, across 3 states.

    Acquisitions include 2 in Texas, 1 in Arizona, and 1 in Wisconsin. The Texas portfolio, similar to the Stonehenge acquisition in Utah, consists of new, high-quality construction in populated and growing metro areas. These are often turnaround acquisitions that initially contribute more to revenue than EPS.

    Risks & headwinds

    3
    Managed care volumes and increased clinical reviewsCurrent

    Discussed, but management states it does not support concern of broad-based slowdown in skilled nursing demand for Ensign. Volatility tends to normalize, resulting in consistently strong occupancy and skilled mix trends.

    Mitigation: Ensign's diversified model across geographies, payers, and referral sources; focus on higher acuity admissions; strong clinical capabilities; dedicated team for clinical review documentation. Management views this as refining demand rather than reducing it.

    Seasonality in occupancy and skilled mixQ2 and Q3 (summer months)

    Not explicitly quantified as a negative impact, but mentioned as a factor that could impact quarterly performance.

    Mitigation: Expected and factored into guidance. Typically, Q2 and Q3 are seasonally lighter for skilled mix, with costs rising relative to revenue as acuity slows down.

    State budget challenges impacting Medicaid ratesBeyond 2026 into 2027

    Not quantified as a current negative impact, but states are looking beyond 2026 into 2027 at potentially less fluid funds.

    Mitigation: Active engagement with states and associations to educate on services and advocate for Medicaid, feeling good about the current position due to recognition of services and need.

    What to watch in Q2 FY26

    4

    Occupancy rates for mature operations

    Ongoing
    Current84% company-wide
    TargetMid-90% range

    Why it matters

    Indicates the embedded organic growth opportunity and efficiency of existing operations.

    At 84% occupancy, we still have meaningful runway with many of our most mature operations, consistently achieving occupancy rates in the mid-90% range.

    Q&A highlights

    6

    Are there broad trends of increased clinical review intensity, especially with Medicare Advantage plans focusing on margin? Does high skilled mix growth in facilities like Sun West trigger higher clinical review?

    Barry Port stated that clinical review is not a new phenomenon and is being 'overblown.' Ensign has a dedicated team for documentation and analysis. They are not seeing a system-wide reduction in admissions or skilled mix, but rather a shift to higher acuity patients. Growth was seen across all skilled payers, including United business, and managed care/Medicare census increased sequentially. Volatility in hospital/managed care volumes tends to normalize for Ensign due to its diversified model.

    I just think the comments around clinical review are being a bit overblown. It's really not a new phenomenon.

    asked by Ben Hendrix · answered by Barry Port

    3 min read7 chapters

    Detailed Narrative

    01

    Operational Excellence and Patient-Focused Culture

    Ensign's consistent financial performance is attributed to a patient-focused culture and empowered frontline teams, leading to exceptional clinical outcomes. This approach allows operations to care for increasingly complex cases, including a larger share of Medicare, managed care, and other skilled patients. The company emphasizes its ability to be the provider of choice through strong clinical capabilities, deep hospital relationships, and the ability to deliver outcomes for higher acuity patients.

    02

    Record Occupancy and Skilled Mix Growth

    Same-store and transitioning occupancy reached new record highs of 84.3% and 85.1%, respectively, during Q1 FY26. Skilled revenue and days for same-store and transitioning operations increased by 9.6% and 5.1% year-over-year, respectively. Medicare revenue also saw significant increases of 9.8% and 9.2% year-over-year. Sequentially, managed care and Medicare census for same-store and transitioning operations increased by 6.2% and 8.3% from Q4 to Q1.

    03

    Strategic Acquisitions and Growth Pipeline

    Since 2024, Ensign has successfully sourced, underwritten, closed, and transitioned 99 new operations. During and since Q1 FY26, 22 new operations were added, including 21 real estate assets, bringing the recently acquired group to 17.4% of the entire portfolio. The company continues to see a robust pipeline of opportunities, ranging from small deals to larger portfolios, including landlords seeking new tenants and non-profits divesting post-acute assets. Ensign's decentralized transition model allows it to effectively integrate these acquisitions.

    04

    Standard Bearer Healthcare REIT Expansion

    Standard Bearer, Ensign's captive real estate investment trust, continues its growth, adding 21 new assets during and since the quarter. It now comprises 173 owned properties, with 137 leased to Ensign-affiliated operators and 37 leased to third-party operators, diversifying its tenant base. For the quarter, Standard Bearer generated $36.1 million in rental revenue, with $30.8 million from Ensign-affiliated operations, and reported $21.6 million in FFO, maintaining an EBITDAR to rent coverage ratio of 2.7x.

    05

    Talent Development and Leadership Stability

    The company highlights its success in attracting and retaining exceptional talent, noting a 32% decline in turnover among Directors of Nursing over the past two years. This leadership stability is a key driver of consistent high-quality care. Ensign's model of developing leaders, exemplified by Mystic Park's CEO transitioning to lead a new market, supports broader organizational growth and allows for scaling without typical corporate bottlenecks, ensuring cultural and clinical standards are maintained.

    06

    Mitigating Managed Care and Clinical Review Concerns

    Management addressed concerns regarding managed care volumes and increased clinical reviews, stating that these dynamics refine demand rather than reduce it. They observe a continued shift towards higher acuity admissions, which aligns with their strengths as a provider of choice for complex patients. Ensign's highly diversified model across geographies, payers, and referral sources allows it to offset market-specific tightening and maintain strong volumes.

    07

    ERP System Implementation

    Ensign implemented its new ERP system on January 1, 2026, and is currently in the initial stages of working through its first quarter and months of closing. While currently in the implementation phase, the system's long-term purpose is to achieve greater efficiency, provide better data, and enable more effective and granular information sharing to the field. The company anticipates significant long-term benefits from this investment.

    AI-generated summary of the company’s earnings call. Not investment advice.